[Doses of biogenetic human insulin for the treatment of diabetics with anti-insulin antibodies]. 1985

D Chadenas, and F de la Forest Divonne, and B Harang, and C Bidault, and D Pinsard, and G Picaper

UI MeSH Term Description Entries
D007328 Insulin A 51-amino acid pancreatic hormone that plays a major role in the regulation of glucose metabolism, directly by suppressing endogenous glucose production (GLYCOGENOLYSIS; GLUCONEOGENESIS) and indirectly by suppressing GLUCAGON secretion and LIPOLYSIS. Native insulin is a globular protein comprised of a zinc-coordinated hexamer. Each insulin monomer containing two chains, A (21 residues) and B (30 residues), linked by two disulfide bonds. Insulin is used as a drug to control insulin-dependent diabetes mellitus (DIABETES MELLITUS, TYPE 1). Iletin,Insulin A Chain,Insulin B Chain,Insulin, Regular,Novolin,Sodium Insulin,Soluble Insulin,Chain, Insulin B,Insulin, Sodium,Insulin, Soluble,Regular Insulin
D007330 Insulin Antibodies Antibodies specific to INSULIN. Antibodies, Insulin
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D011994 Recombinant Proteins Proteins prepared by recombinant DNA technology. Biosynthetic Protein,Biosynthetic Proteins,DNA Recombinant Proteins,Recombinant Protein,Proteins, Biosynthetic,Proteins, Recombinant DNA,DNA Proteins, Recombinant,Protein, Biosynthetic,Protein, Recombinant,Proteins, DNA Recombinant,Proteins, Recombinant,Recombinant DNA Proteins,Recombinant Proteins, DNA
D003920 Diabetes Mellitus A heterogeneous group of disorders characterized by HYPERGLYCEMIA and GLUCOSE INTOLERANCE.
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly

Related Publications

D Chadenas, and F de la Forest Divonne, and B Harang, and C Bidault, and D Pinsard, and G Picaper
December 1983, Science (New York, N.Y.),
D Chadenas, and F de la Forest Divonne, and B Harang, and C Bidault, and D Pinsard, and G Picaper
January 1978, Acta medica Iugoslavica,
D Chadenas, and F de la Forest Divonne, and B Harang, and C Bidault, and D Pinsard, and G Picaper
January 1984, Minerva endocrinologica,
D Chadenas, and F de la Forest Divonne, and B Harang, and C Bidault, and D Pinsard, and G Picaper
April 1971, Journal of immunology (Baltimore, Md. : 1950),
D Chadenas, and F de la Forest Divonne, and B Harang, and C Bidault, and D Pinsard, and G Picaper
August 1964, La Clinica terapeutica,
D Chadenas, and F de la Forest Divonne, and B Harang, and C Bidault, and D Pinsard, and G Picaper
October 1978, Minerva medica,
D Chadenas, and F de la Forest Divonne, and B Harang, and C Bidault, and D Pinsard, and G Picaper
July 1982, Lancet (London, England),
D Chadenas, and F de la Forest Divonne, and B Harang, and C Bidault, and D Pinsard, and G Picaper
July 1989, Presse medicale (Paris, France : 1983),
D Chadenas, and F de la Forest Divonne, and B Harang, and C Bidault, and D Pinsard, and G Picaper
January 1987, Medicinski arhiv,
D Chadenas, and F de la Forest Divonne, and B Harang, and C Bidault, and D Pinsard, and G Picaper
October 1987, Presse medicale (Paris, France : 1983),
Copied contents to your clipboard!